Ajanta Pharma Limited (NSE:AJANTPHARM)
2,477.60
-30.70 (-1.22%)
Aug 29, 2025, 3:29 PM IST
Ajanta Pharma Employees
Ajanta Pharma had 9,628 employees as of March 31, 2025. The number of employees increased by 1,555 or 19.26% compared to the previous year.
Employees
9,628
Change (1Y)
1,555
Growth (1Y)
19.26%
Revenue / Employee
4.99M INR
Profits / Employee
965.89K INR
Market Cap
309.42B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 9,628 | 1,555 | 19.26% |
Mar 31, 2024 | 8,073 | 360 | 4.67% |
Mar 31, 2023 | 7,713 | 479 | 6.62% |
Mar 31, 2022 | 7,234 | 199 | 2.83% |
Mar 31, 2021 | 7,035 | -132 | -1.84% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 42,497 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Alkem Laboratories | 18,785 |
Ajanta Pharma News
- 10 days ago - Top stocks to watch today, August 21: Godrej Properties, RailTel, Ajanta Pharma, India Cements and more - Business Upturn
- 10 days ago - Ajanta Pharma confirms IT raid reports, says business operations remain unaffected - Business Upturn
- 12 days ago - Ajanta Pharma shares fall 3% after reports of Income Tax raids - Business Upturn
- 12 days ago - Ajanta Pharma in focus as Income Tax raid underway at company premises - Business Upturn
- 4 weeks ago - Top stocks to buy today: Stock recommendations for July 31, 2025 - check list - The Times of India
- 4 months ago - Ajanta Pharma Q4 Results: Net profit grows 11% YoY to Rs 225 crore, EBITDA Margin at 25% - Business Upturn
- 4 months ago - Stocks to buy today on brokerages’ call: IndiGo, Ajanta Pharma, TBO, HDFC Bank, Vodafone Idea among top picks – Check investment target - Business Upturn
- 4 months ago - Jefferies initiates Buy on Ajanta Pharma, sees 11% upside due to strong presence in branded generics markets - Business Upturn